Annual Current Liabilities
$1.06 M
+$623.10 K+141.52%
December 1, 2023
Summary
- As of February 7, 2025, BRTX annual total current liabilities is $1.06 million, with the most recent change of +$623.10 thousand (+141.52%) on December 1, 2023.
- During the last 3 years, BRTX annual current liabilities has risen by +$18.60 thousand (+1.78%).
- BRTX annual current liabilities is now -92.25% below its all-time high of $13.72 million, reached on December 31, 2019.
Performance
BRTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$4.58 M
-$738.30 K-13.88%
September 1, 2024
Summary
- As of February 7, 2025, BRTX quarterly total current liabilities is $4.58 million, with the most recent change of -$738.30 thousand (-13.88%) on September 1, 2024.
- Over the past year, BRTX quarterly current liabilities has increased by +$3.65 million (+391.26%).
- BRTX quarterly current liabilities is now -75.12% below its all-time high of $18.42 million, reached on March 31, 2020.
Performance
BRTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
BRTX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +141.5% | +391.3% |
| 3 y3 years | +1.8% | +1159.3% |
| 5 y5 years | -88.5% | +1159.3% |
BRTX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +192.3% | -23.4% | +1159.3% |
| 5 y | 5-year | -92.3% | +192.3% | -75.1% | +1159.3% |
| alltime | all time | -92.3% | +192.3% | -75.1% | +1159.3% |
BioRestorative Therapies Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.58 M(-13.9%) |
| Jun 2024 | - | $5.32 M(+54.3%) |
| Mar 2024 | - | $3.45 M(+32.2%) |
| Dec 2023 | $1.06 M(+141.5%) | $2.61 M(+179.6%) |
| Sep 2023 | - | $932.60 K(+14.7%) |
| Jun 2023 | - | $812.90 K(+72.8%) |
| Mar 2023 | - | $470.40 K(-92.1%) |
| Dec 2022 | $440.30 K(+21.0%) | $5.98 M(+734.1%) |
| Sep 2022 | - | $717.20 K(+15.3%) |
| Jun 2022 | - | $621.80 K(+25.9%) |
| Mar 2022 | - | $493.80 K(+35.7%) |
| Dec 2021 | $363.80 K(-65.2%) | $363.80 K(-58.4%) |
| Sep 2021 | - | $873.50 K(-34.1%) |
| Jun 2021 | - | $1.33 M(+2.7%) |
| Mar 2021 | - | $1.29 M(+23.6%) |
| Dec 2020 | $1.04 M(-92.4%) | $1.04 M(-24.0%) |
| Sep 2020 | - | $1.37 M(+55.9%) |
| Jun 2020 | - | $881.50 K(-95.2%) |
| Mar 2020 | - | $18.42 M(+34.2%) |
| Dec 2019 | $13.72 M(+48.3%) | $13.72 M(+0.0%) |
| Sep 2019 | - | $13.72 M(+23.1%) |
| Jun 2019 | - | $11.14 M(+27.7%) |
| Mar 2019 | - | $8.73 M(-5.7%) |
| Dec 2018 | $9.25 M(+10.8%) | $9.25 M(+3.7%) |
| Sep 2018 | - | $8.92 M(-16.2%) |
| Jun 2018 | - | $10.65 M(+20.7%) |
| Mar 2018 | - | $8.82 M(+5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $8.35 M(+42.9%) | $8.35 M(+3.8%) |
| Sep 2017 | - | $8.04 M(+15.0%) |
| Jun 2017 | - | $6.99 M(+15.4%) |
| Mar 2017 | - | $6.06 M(+3.7%) |
| Dec 2016 | $5.84 M(+4.1%) | $5.84 M(+5.3%) |
| Sep 2016 | - | $5.55 M(-2.6%) |
| Jun 2016 | - | $5.70 M(+1.9%) |
| Mar 2016 | - | $5.59 M(-0.4%) |
| Dec 2015 | $5.61 M(-34.2%) | $5.61 M(+2.7%) |
| Sep 2015 | - | $5.47 M(+11.1%) |
| Jun 2015 | - | $4.92 M(-44.9%) |
| Mar 2015 | - | $8.92 M(+4.7%) |
| Dec 2014 | $8.53 M(+13.6%) | $8.53 M(+14.8%) |
| Sep 2014 | - | $7.43 M(-10.1%) |
| Jun 2014 | - | $8.26 M(+4.2%) |
| Mar 2014 | - | $7.93 M(+5.7%) |
| Dec 2013 | $7.50 M(+166.4%) | $7.50 M(-4.5%) |
| Sep 2013 | - | $7.86 M(+134.3%) |
| Jun 2013 | - | $3.35 M(+9.6%) |
| Mar 2013 | - | $3.06 M(+8.6%) |
| Dec 2012 | $2.82 M(-27.9%) | $2.82 M(-56.5%) |
| Sep 2012 | - | $6.48 M(+15.6%) |
| Jun 2012 | - | $5.60 M(+26.9%) |
| Mar 2012 | - | $4.41 M(+13.0%) |
| Dec 2011 | $3.91 M(+284.6%) | $3.91 M(+4.3%) |
| Sep 2011 | - | $3.75 M(+268.8%) |
| Dec 2010 | $1.02 M | $1.02 M |
FAQ
- What is BioRestorative Therapies annual total current liabilities?
- What is the all time high annual current liabilities for BioRestorative Therapies?
- What is BioRestorative Therapies annual current liabilities year-on-year change?
- What is BioRestorative Therapies quarterly total current liabilities?
- What is the all time high quarterly current liabilities for BioRestorative Therapies?
- What is BioRestorative Therapies quarterly current liabilities year-on-year change?
What is BioRestorative Therapies annual total current liabilities?
The current annual current liabilities of BRTX is $1.06 M
What is the all time high annual current liabilities for BioRestorative Therapies?
BioRestorative Therapies all-time high annual total current liabilities is $13.72 M
What is BioRestorative Therapies annual current liabilities year-on-year change?
Over the past year, BRTX annual total current liabilities has changed by +$623.10 K (+141.52%)
What is BioRestorative Therapies quarterly total current liabilities?
The current quarterly current liabilities of BRTX is $4.58 M
What is the all time high quarterly current liabilities for BioRestorative Therapies?
BioRestorative Therapies all-time high quarterly total current liabilities is $18.42 M
What is BioRestorative Therapies quarterly current liabilities year-on-year change?
Over the past year, BRTX quarterly total current liabilities has changed by +$3.65 M (+391.26%)